SKINVIVE in Toronto

SKINVIVE by Juvéderm is an injectable skin booster made by Allergan Aesthetics, the company behind Botox and the Juvéderm dermal filler range. It's a smooth hyaluronic acid gel placed into the skin as a series of tiny microdroplet injections. Rather than adding volume the way a filler does, the hyaluronic acid stays within the skin and draws in water, improving hydration, smoothness, and glow from the inside. Health Canada approved it in September 2023 for the cheeks, forehead, and neck, to soften fine lines and improve hydration. It's suitable for all skin tones and types, and the gel includes lidocaine for comfort during treatment.

Both use hyaluronic acid, but for different jobs. A dermal filler is a firmer gel placed deeper in the face to restore volume and structure: cheekbones, lips, jawline, deeper folds. SKINVIVE is a much softer gel placed as microdroplets within the skin itself, where it hydrates and smooths without adding volume or changing your features. Think of filler as working on the shape of the face and SKINVIVE as working on the condition of the skin. They're often used together in one plan, filler for structure and SKINVIVE for surface quality. If your concern is dullness, dryness, or fine surface lines rather than lost volume, SKINVIVE is the more precise match.

Yes. Health Canada approved SKINVIVE by Juvéderm on September 21, 2023 for treatment of the face (cheek and forehead) and neck, filling superficial fine lines and improving skin hydration. In the clinical study supporting the approval, 90.8% of patients reported improved satisfaction with their skin one month after treatment, and the product showed hydration benefits lasting up to nine months. SKINVIVE is also approved in the United States, where the FDA cleared it for improving cheek skin smoothness in adults over 21. Approval means the product's safety and performance data have been reviewed by the regulator, which is not true of every injectable marketed as a skin booster.

From a single treatment, Allergan's Canadian data shows improved skin hydration for up to nine months and improved texture for up to six months. The hyaluronic acid microdroplets are gradually and naturally broken down by the body, the same way the HA in dermal fillers is, so the effect tapers rather than stopping abruptly. Most people plan a repeat treatment as the result fades to keep skin quality consistent through the year. Because SKINVIVE doesn't change facial shape, letting it wear off simply returns the skin to its previous condition; there's nothing to correct or reverse. The consultation covers a realistic maintenance rhythm for your skin and goals.

Very little for most people. The common side effects are redness, small bumps at the injection points, mild swelling, bruising, tenderness, and occasionally itching, and these typically resolve within about a week. The small bumps are normal with microdroplet treatments and settle as the gel integrates into the skin. Most clients return to their day straight after the appointment. As with any injectable, standard advice is to keep the area clean and avoid pressure on it while the injection points close. Serious complications are rare but possible with any injection into the face, which is one reason injectable treatments belong in a clinic with medically trained staff rather than anywhere less accountable.

SKINVIVE is typically priced per treatment, with the amount of product depending on the areas being treated: cheeks alone use less than cheeks, forehead, and neck together. Because results from a single treatment last up to six months for texture and nine for hydration, the cost is usually weighed against half a year or more of effect rather than a single appointment. At Lucie Mé, the exact cost for the areas you want to treat is confirmed at the complimentary consultation, along with how SKINVIVE would sequence with any other treatments you're considering.

SKINVIVE isn't suitable for anyone with a history of severe allergic reactions or anaphylaxis, or with an allergy to lidocaine or the Gram-positive bacterial proteins used in manufacturing the gel. Active skin infection or inflammation in the treatment area needs to settle before injecting. Pregnancy and breastfeeding are standard reasons to defer cosmetic injectable treatment. If you have a history of significant scarring, pigmentation disorders, or are on medications that affect bleeding, these should be raised at the consultation. The medical history review before treatment exists to catch all of this; answer it fully and the treatment plan is built around what's safe for you.